Uso del NutriScore y evaluación de la capacidad funcional en los pacientes oncológicos ambulatorios

Ornella Agostina Capelli; Pilar Navarro; Julieta Adaglio

doi:10.35454/rncm.v5n4.419

Autores

Ornella Agostina Capelli HOSPITAL UNIVERSITARIO CEMIC https://orcid.org/0000-0002-4618-0057
Pilar Navarro https://orcid.org/0000-0002-6682-2184
Julieta Adaglio https://orcid.org/0000-0001-7916-7759

DOI:

https://doi.org/10.35454/rncm.v5n4.419

Palavras-chave:

ECOG, NutriScore, Evaluación nutricional, Paciente oncológico

Resumo

Introdução: a má nutrição é comum em pacientes com câncer e está relacionada à diminuição de sua capacidade funcional. O NUTRISCORE é uma ferramenta específica para medir o risco de desnutrição em pacientes oncológicos ambulatoriais.

Objetivo: conhecer o risco nutricional e a capacidade funcional dos pacientes atendidos no Hospital de Día de Oncología do Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC).

Materiais e métodos: estudo descritivo, observacional, transversal e prospectivo. Amostragem não probabilística. Foi realizado o NUTRISCORE e a escala ECOG. Foi indagada a presença de sintomas relacionados à ingestão alimentar e à restrição alimentar. Foram calculadas a Média, o desvio padrão, a frequência absoluta e relativa conforme corresponda. A associação entre as variáveis foi estabelecida de acordo com o Qui quadrado.

Resultados: um total de 200 pacientes foram incluídos. O 7 % apresentou risco de desnutrição e o 36,5 % teve excesso de peso, de acordo com o IMC. O estado funcional foi preservado em 90,5 %. O 62 % apresentaram sintomas gastrointestinais, sendo os mais frequentes anorexia e constipação. O 33 % eliminaram algum alimento de sua ingestão, sendo os mais

frequentes os laticínios e os alimentos com glúten. O risco nutricional foi significativamente associado ao tipo de tumor (p = 0,002), tipo de terapia (p = 0,015) e tipo de tratamento (p = 0,032).

Conclusões: o risco de desnutrição nos pacientes segundo o NUTRISCORE foi menor do que o descrito na literatura e não esteve associado à capacidade funcional.

Downloads

Não há dados estatísticos.

Referências

Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187-96. doi: 10.1016/j.clnu.2017.06.017.

de Las Peñas R, Majem M, Perez-Altozano J, Virizuela JA, Cancer E, Diz P, et al. SEOM clinical guidelines on nutrition in cancer patients (2018). Clin Transl Oncol. 2019;21(1):87-93. doi: 10.1007/s12094-018-02009-3.

Reber E, Schönenberger KA, Vasiloglou MF, Stanga Z. Nutritional risk screening in cancer patients: the first step toward better clinical outcome. Front Nutr. 2021;8:152. doi: 10.3389/fnut.2021.603936.

Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clin Nutr Cancer. Clin Nutr. 2021;40(5):2898-913. doi: 10.1016/j.clnu.2021.02.005.

Arribas L, Hurtós L, Sendrós MJ, Peiró I, Salleras N, Fort E, et al. NUTRISCORE: a new nutritional screening tool for oncological outpatients. Nutrition. 2017;33:297-303. doi: 10.1016/j.nut.2016.07.015.

Álvaro Sanz E, Garrido Siles M, Rey Fernández L, Villatoro Roldán R, Rueda Domínguez A, Abilés J. Nutritional risk and malnutrition rates at diagnosis of cancer in patients treated in outpatient settings: early intervention protocol. Nutrition. 2019;57:148-53. doi: 10.1016/j.nut.2018.05.021.

Álvaro Sanz E, Abilés J, Garrido Siles M, Rivas Ruíz F, Tortajada Goitia B, Domínguez AR. Evaluation of a protocol to detect malnutrition and provide nutritional care for cancer patients undergoing chemotherapy. Scient Rep. 2020;10(1):1-8. doi: 10.1038/s41598-020-78246-w

Canicoba M, Baptista G, Visconti G. Documento de consenso: funciones y competencias del nutricionista clínico. Rev Cubana Aliment Nutr. 2013;23(1):146-72.

Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO open. 2021;6(3):100092. doi: 10.1016/j.esmoop.2021.100092.

Dolan RD, Daly LE, Simmons CP, Ryan AM, Sim WM, Fallon M, et al. The relationship between ECOG-PS, mGPS, BMI/WL grade and body composition and physical function in patients with advanced cancer. Cancers (Basel). 2020;12(5):1187. doi: 10.3390/cancers12051187.

de Vries YC, van den Berg MMGA, de Vries JHM, Boesveldt S, de Kruif JTCM, Buist N, et al. Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer. Support Care Cancer. 2017;25(8):2581-91. doi: 10.1007/s00520-017-3668-x.

Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers. 2019;11(12):1861. doi: 10.3390/cancers11121861.

Steinmeyer Z, Gérard S, Filleron T, Lozano S, Brechemier D, Abellan Van Kan G, et al. Low lean mass and chemotherapy toxicity risk in the elderly: the fraction study protocol. BMC cancer. 2019;19(1):1-8. doi: 10.1186/s12885-019-6377-7.

Martin L, Gioulbasanis I, Senesse P, Baracos VE. Cancer‐associated malnutrition and CT defined sarcopenia and myosteatosis are endemic in overweight and obese patients. J Parent Enteral Nutr. 2020;44(2):227-38. doi: 10.1002/jpen.1597.

Rocculi MT, Mercuri M, Ross AM. Sobrepeso, obesidad y síndrome metabólico. Estado de situación del paciente oncológico en nuestro medio. Rev Bioquím Patol Clín. 2020;84(1):13-8.

Flores-Cisneros L, Castro-Eguiluz D, Reyes-Barretero DY, Jaimes E, Cano-Blanco C, Avendaño-Pérez C, et al. Effects of dietary components during and after concomitant chemoradiotherapy, radiotherapy, or sequential chemoradiotherapy to the abdominopelvic area. Rev Invest Clín. 2018;70(3):126-9. doi: 10.24875/RIC.18002525.

Kang WX, Li W, Huang SG, Dang Y, Gao H. Effects of nutritional intervention in head and neck cancer patients undergoing radiotherapy: A prospective randomized clinical trial. Molec Clin Oncol. 2016;5(3):279-82. doi: 10.3892/mco.2016.943.

Kurk S, Peeters P, Stellato R, Dorresteijn B, de Jong P, Jourdan M, et al. Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients. J Cachexia Sarcopenia Muscle. 2019;10(4):803-13. doi: 10.1002/jcsm.12436.

Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition. 2019;67-68:110539. doi: 10.1016/j.nut.2019.06.020.

Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):366-80. doi: 10.1002/jcsm.12525.

Cessot A, Coriat R, Mir O, Boudou-Rouquette P, Giroux J, Durand JP, et al. Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancer. Nutr Cancer. 2013;65(8):1254-7. doi: 10.1080/01635581.2013.830315.

Bozzetti F, Mariani L, Lo Vullo S; SCRINIO Working Group, Amerio ML, Biffi R, et al. The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer. 2012; 20(8):1919-28. doi: 10.1007/s00520-012-1387-x.

Sullivan ES, Rice N, Kingston E, Kelly A, Reynolds JV, Feighan J, et al. A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey. Clin Nutr ESPEN. 2021;41:331-9. doi: 10.1016/j.clnesp.2020.10.023.

Hernández R, Fernández C, Baptista P. Muestreo en la investigación cualitativa. En: Metodología de la investigación. 6.a edición. México D.F.: Mcgraw-Hill/Interamericana Editores; 2014. p. 390-2.

Sullivan KM, Dean A, Soe MM. On academics: OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Reports. 2009;124(3):471-4. (Consultado el 26 de marzo 2021). Disponible en: http://www.openepi.com/Menu/OE_Menu.htm

World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity. Geneva: World Health Organization; 1998. p. 3-5.

Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21(1):55-67.

Edición electrónica de la CIE-10-ES diagnósticos. 3.ª edición. 2021. (Consultado el 19 de mayo 2021). Disponible en: https://eciemaps.mscbs.gob.es/ecieMaps/browser/index_10_mc.html

Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Registros de cáncer: principios y métodos. Lyon, Francia: IARC. Publicación científica No. 95. 1995.

Gómez C, Peña M, de Cos Blanco AI, Iglesias Rosado C, Castillo R. Evaluación del estado nutricional en el paciente oncológico. En: Gómez, Sastre A. Soporte nutricional en el paciente oncológico. Madrid, España: You & Us; 2002. p. 43-56.

Pérez-Cruz PE, Acevedo CF. Escalas de estado funcional (o performance status) en cáncer. Gastroenterol Latinoam. 2014;25(3):219-26.

Bosch X, Monclús E, Escoda O, Guerra-García M, Moreno P, Guasch N, et al. Unintentional weight loss: clinical characteristics and outcomes in a prospective cohort of 2677 patients. PloS one. 2017;12(4). doi: 10.1371/journal.pone.0175125.

Kang J, Li H, Shi X, Ma E, Chen W. Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China. BMC Cancer. 2022;22(1):43. doi: 10.1186/s12885-021-09135-2.

Leuenberger M, Kurmann S, Stanga Z. Nutritional screening tools in daily clinical practice: the focus on cancer. Support Care Cancer. 2010;18(2):17-27. doi: 10.1007/s00520-009-0805-1.

Trujillo EB, Dixon SW, Claghorn K, Levin RM, Mills JB, Spees CK. Closing the gap in nutrition care at outpatient cancer centers: ongoing initiatives of the oncology nutrition dietetic practice group. J Acad Nutr Diet. 2018;118(4):749-60. doi: 10.1016/j.jand.2018.02.010.